DoD grant to fund prostate cancer bone metastases research
June 26, 2024
June 26, 2024
ITHACA, New York, June 26 -- Cornell University issued the following news:
Weill Cornell Medicine received a $1.5 million grant from the U.S. Department of Defense Prostate Cancer Research Program to develop new approaches for predicting the spread of cancer cells to the bone in men with prostate cancer, using tumor samples taken at early stages of the disease.
"Metastases, especially to the bone, is the leading cause of death in men who have prostate cancer," . . .
Weill Cornell Medicine received a $1.5 million grant from the U.S. Department of Defense Prostate Cancer Research Program to develop new approaches for predicting the spread of cancer cells to the bone in men with prostate cancer, using tumor samples taken at early stages of the disease.
"Metastases, especially to the bone, is the leading cause of death in men who have prostate cancer," . . .